The biology of PD-1/PD-L1 in modulating innate immune responses to acute injury is a growing topic of interest and appears to have wide-ranging implications, particularly in cerebrovascular injury, including ischemic stroke, ICH, SAH-related vasospasm, and TBI. The gene discussed is PDCD1; the disease is ischemic stroke.